OTCMKTS:CGNH - CardioGenics Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.0169 0.00 (0.00 %)
(As of 04/19/2019 04:00 PM ET)
Previous Close$0.0169
Today's Range$0.0130 - $0.0169
52-Week Range$0.0048 - $0.04
Volume24,400 shs
Average Volume88,263 shs
Market Capitalization$1.96 million
P/E RatioN/A
Dividend YieldN/A
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market in the United States, Canada, Europe, and internationally. Its products include QL Care Analyzer, a portable, stand-alone, and automated point-of-care (POC) immunoassay analyzer that uses a proprietary self-metering cartridge to perform immunoassay tests at the POC; a series of immunoassay tests to identify cardiac markers in the blood at the time of a heart attack; and paramagnetic beads that are used as solid surfaces in heterogeneous immunoassay tests by clinical and research laboratories. The company was formerly known as Jag Media Holdings, Inc. and changed its name to CardioGenics Holdings Inc. in 2009. The company was founded in 1997 and is headquartered in Mississauga, Canada.

Receive CGNH News and Ratings via Email

Sign-up to receive the latest news and ratings for CGNH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Business services, not elsewhere classified
Current SymbolOTCMKTS:CGNH



Sales & Book Value

Annual SalesN/A



Market Cap$1.96 million
Next Earnings DateN/A
OptionableNot Optionable

CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

Has CardioGenics been receiving favorable news coverage?

Media headlines about CGNH stock have trended positive recently, according to InfoTrie Sentiment Analysis. The research firm identifies negative and positive media coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. CardioGenics earned a coverage optimism score of 2.6 on InfoTrie's scale. They also assigned headlines about the company a news buzz of 3.0 out of 10, indicating that recent media coverage is unlikely to have an impact on the stock's share price in the next several days.

Who are some of CardioGenics' key competitors?

What other stocks do shareholders of CardioGenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CardioGenics investors own include Trinity Biotech (TRIB), Rock Creek Pharmaceuticals (RCPIQ) and Canopy Growth (CGC).

Who are CardioGenics' key executives?

CardioGenics' management team includes the folowing people:
  • Dr. Yahya Abdul Gawad MB, Ch.B., M.D., MSc., Chief Exec. Officer and Director (Age 61)
  • Mr. James A. Essex CA, MBA, Chief Financial Officer (Age 70)
  • Ms. Linda J. Stering F.Inst.L.C.O., Sec. & Director (Age 58)

How do I buy shares of CardioGenics?

Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is CardioGenics' stock price today?

One share of CGNH stock can currently be purchased for approximately $0.0169.

How big of a company is CardioGenics?

CardioGenics has a market capitalization of $1.96 million. CardioGenics employs 4 workers across the globe.

What is CardioGenics' official website?

The official website for CardioGenics is http://www.cardiogenics.com.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at 905-673-8501 or via email at [email protected]

MarketBeat Community Rating for CardioGenics (OTCMKTS CGNH)

Community Ranking:  3.2 out of 5 (star star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  84
MarketBeat's community ratings are surveys of what our community members think about CardioGenics and other stocks. Vote "Outperform" if you believe CGNH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CGNH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 4/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel